5.44 - 5.64
4.95 - 8.28
2.1K / 2.4K (Avg.)
-272.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.22%
Negative revenue growth while HUH1V.HE stands at 12.36%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
5.30%
Gross profit growth under 50% of HUH1V.HE's 24.31%. Michael Burry would be concerned about a severe competitive disadvantage.
4125.00%
EBIT growth above 1.5x HUH1V.HE's 45.43%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
4125.00%
Operating income growth above 1.5x HUH1V.HE's 45.43%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
1033.33%
Net income growth above 1.5x HUH1V.HE's 53.44%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
972.21%
EPS growth above 1.5x HUH1V.HE's 58.33%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
972.21%
Diluted EPS growth above 1.5x HUH1V.HE's 58.33%. David Dodd would see if there's a robust moat protecting these shareholder gains.
7.56%
Share count expansion well above HUH1V.HE's 0.03%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
7.56%
Diluted share count expanding well above HUH1V.HE's 0.03%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-214.29%
Negative OCF growth while HUH1V.HE is at 1996.15%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-372.22%
Negative FCF growth while HUH1V.HE is at 402.68%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-9.55%
Negative 10Y revenue/share CAGR while HUH1V.HE stands at 30.29%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-9.55%
Negative 5Y CAGR while HUH1V.HE stands at 30.29%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-9.55%
Negative 3Y CAGR while HUH1V.HE stands at 30.29%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-62.18%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-62.18%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-62.18%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
249.37%
Net income/share CAGR above 1.5x HUH1V.HE's 59.97% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
249.37%
5Y net income/share CAGR above 1.5x HUH1V.HE's 59.97%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
249.37%
3Y net income/share CAGR above 1.5x HUH1V.HE's 59.97%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2.33%
Inventory is declining while HUH1V.HE stands at 7.20%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-0.65%
Negative asset growth while HUH1V.HE invests at 9.08%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
3.01%
BV/share growth above 1.5x HUH1V.HE's 0.71%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-0.53%
We’re deleveraging while HUH1V.HE stands at 22.51%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.